Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
---|
03/18/2004 | WO2004022532A1 Benzenesulphonamides and process for their preparation |
03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
03/18/2004 | WO2004022525A1 Amide derivatives and their use as chloride channel blockers |
03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
03/18/2004 | WO2003097576A3 Diamino-functional chalcones |
03/18/2004 | WO2003086563A3 Diabetes imaging probes |
03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
03/18/2004 | US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders |
03/18/2004 | US20040053983 1, 2, 4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
03/18/2004 | US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
03/18/2004 | US20040053907 Cell adhesion inhibitors |
03/18/2004 | US20040053890 Naphthalene derivatives |
03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
03/17/2004 | EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy |
03/17/2004 | EP1146865B9 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
03/17/2004 | EP1140810B1 Benzenic sulphonamide derivatives and their uses |
03/17/2004 | EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
03/17/2004 | CN1482116A Coffee acyl naphthalene sulfonamides compound and method for preparing the same and anti HIV conformity enzyme action |
03/17/2004 | CN1142137C 2-naphtylamine-6-sulfonyl aniline and its prepn and application |
03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
03/16/2004 | US6706744 Hypoglycemic agents; antidiabetic agents |
03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
03/16/2004 | CA2139348C Improved chemiluminescent 1,2-dioxetanes |
03/11/2004 | WO2004021500A1 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery |
03/11/2004 | WO2004020402A1 Sulphonylamino derivatives for the treatment of alzheimer's disease |
03/11/2004 | WO2004020401A1 Synthesis of sulfonamide derivatives |
03/11/2004 | US20040049041 Acylation, deacylation, resolution |
03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
03/11/2004 | US20040048928 Containing an amide or sulfonamide group; sunscreens for human skin and/or hair, as well as glass, plastic, textile, paint, varnish, or foodstuff. |
03/11/2004 | US20040048909 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis |
03/11/2004 | US20040048897 Il-8 receptor antagonists |
03/11/2004 | US20040048895 Caspase-1 inhibitors and methods for their use |
03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
03/11/2004 | US20040048856 Monoamine reuptake inhibitors for treatment of CNS disorders |
03/11/2004 | US20040048851 Amidinophenylalanine derivatives as thrombin inhibitors |
03/11/2004 | US20040048834 Antitumoral compounds |
03/11/2004 | DE10240260A1 Formation of heteroatom-carbon bonds, giving products of interest for the pharmaceutical and agrochemical industries, comprises using an organolithium compound prepared by reacting an aliphatic or aromatic halide with lithium |
03/11/2004 | CA2497109A1 Nonaqueous electrolyte and nonaqueous electrolyte secondary battery |
03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
03/10/2004 | EP1395550A1 Cycloalkenylsulfonamide derivatives |
03/10/2004 | EP1395549A1 Compounds and methods for preparing methanesulfonamides |
03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
03/10/2004 | EP1084101B1 New 3-aryl-2-hydroxypropionic acid derivative iii |
03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
03/10/2004 | CN1480455A 'Sqiqu site' ramification and its preparing method as well as its activity of anti asthma |
03/09/2004 | US6703468 Composition for topical administration to skin or hair comprising suitable carrier and effective amount of specified polymer which has beneficial effects on skin functions |
03/09/2004 | US6703467 Adhesives and sealants |
03/09/2004 | US6703425 Sulfonamide derivatives |
03/09/2004 | US6703379 Benzene derivatives and pharmaceutical use thereof |
03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
03/09/2004 | US6702705 Prodrugs activated by targeted catalytic proteins |
03/04/2004 | WO2004018461A2 Antibacterial benzoic acid derivatives |
03/04/2004 | WO2004018415A1 Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof |
03/04/2004 | WO2004018414A2 Antibacterial agents |
03/04/2004 | WO2003075907A3 Small molecule entry inhibitors |
03/04/2004 | WO2003045878A3 2,w-diaminocarboxylic acid compounds |
03/04/2004 | WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy |
03/04/2004 | US20040044081 Hypotensive agents; cardiovascular disorders; anticholesterol agents; antiarrhythmia agents |
03/04/2004 | US20040044072 Substituted hydroxyethylamines |
03/04/2004 | US20040044061 Analgesics; side effect reduction |
03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
03/03/2004 | EP1394175A1 Inhibitors of interleukin-1beta converting enzyme |
03/03/2004 | EP1392645A2 Aza hydroxylated ethyl amine compounds |
03/03/2004 | EP1392643A2 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
03/03/2004 | EP1124797B1 N-arylsulfonyl amino acid omega amides |
03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
03/03/2004 | EP1007509B1 Antimicrobial compounds |
03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
03/03/2004 | CN1140513C Phenylsulphenyl ureas, process for their preparation and their use as herbicides and plant-growth regulators |
03/03/2004 | CN1140498C Novel antiarrhythmic compounds |
03/02/2004 | US6699990 Colorfastness; waterproofing; oxidative color hair dyes |
03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
03/02/2004 | US6699893 Glucocorticoid receptor modulators |
03/02/2004 | US6699891 Npyy5 antagonists |
03/02/2004 | US6699650 Yield cyan images of good hue, with good stability to heat, humidity and light, whilst retaining the other properties desirable for good photographic performance |
03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
02/26/2004 | WO2004016582A1 An improved process for the preparation of tamsulosin hydrochloride |
02/26/2004 | WO2004016578A2 Arylethanolamine beta2-adrenoreceptor agonist compounds |
02/26/2004 | WO2004016221A2 Sulfonamides as potassium channel blockers |
02/26/2004 | WO2003097575A3 Amino-functional chalcones |
02/26/2004 | WO2003097574A3 Aminoalkoxy-functional chalcones |
02/26/2004 | WO2003074008A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
02/26/2004 | WO2002098424B1 Novel anti-infectives |
02/26/2004 | WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
02/26/2004 | US20040039142 Chemical resistant fluoropolymers used as separators or binders in electrodes for batteries and fuel cells |
02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
02/26/2004 | US20040039016 HIV protease inhibitors |
02/26/2004 | US20040038976 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
02/26/2004 | US20040038127 Small cation/delocalizing anion as an ambient temperature molten salt in electrochemical power sources |
02/26/2004 | US20040037022 Aminoalcohol derivatives |
02/26/2004 | US20040035293 Melt point is < 100 degrees c; provides distinct selectivities and reactivities because they are made of ions rather than molecules |